Disclosures

A-B | C-D | E-H | I-L | M-N | O-S | T-Z

Alphabetical List

 

Ian Adatia has received Institutional Grant/Research Support from WCHRI Alberta, Canadian Medical Protective Agency Research Grant, Cardiovascualr Medical Education Research Fund for Pulmonary Hypertension.

Marjorie Albrecht has no relevant personal financial relationship to disclose. 

Rino Aldrighetti has no relevant personal financial relationships to disclose.

Nadine Al-Naamani has no relevant personal financial relationship to disclose.

Kousei Araki has no relevant personal financial relationship to disclose.

Christine Archer-Chicko has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals.

Katherine Athanasiou has no relevant personal financial relationship to disclose.

Robert Aris has received non-Institutional/Research Support from Gilead Sciences.

Abraham Babu has Other Disclosure for Pulmonary Hypertension Association.

David Badesch has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals, Gilead Sciences, Bayer HealthCare, Ikaria, Arena, United Therapeutics Corporation, Lung LLC, Johnson & Johnson. In addition, he has received Institutional Grant/Research Support from Actelion Pharmaceuticals, Gilead Sciences, United Therapeutics Corporation, Lung LLC, Bayer HealthCare, Ikaria, Reatta, AIRES. In addition, he has been a Stock Shareholder of Johnson & Johnson.

Nancy Bair has no relevant personal financial relationship to disclose.

Mukta Barve has no relevant personal financial relationship to disclose.

Vikas Batra has served on a Speaker’s Bureau for Forrest Pharmaceuticals.

Raymond Benza receives grant support from Gilead Sciences, Inc.; United Therapeutics Corporation; Ikaria, Inc. and GeNO; and is an advisory board member for Bayer HealthCare and a steering committee member for Actelion Pharmaceuticals US, Inc.

Deedre Boekweg has served as a Consultant/Advisory Board/Steering Committee member for United Therapeutics Corporation.

Daniel Bourque has no relevant personal financial relationship to disclose.

Monika Brand has been a Stock Shareholder of Actelion Pharmaceuticals. She also has Other Disclosure for Actelion Pharmaceuticals.

Mary Beth Brown has no relevant personal financial relationship to disclose.

Kacie Brumley has no relevant personal financial relationship to disclose.

Colleen Brunetti has no relevant personal financial relationship to disclose.

Todd Bull receives grant support from United Therapeutics Corporation.

Charles Burger has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals, Gilead Sciences, United Therapeutics Corporation. In addition, she has received Institutional Grant/Research Support from Actelion Pharmaceuticals, Gilead Sciences, United Therapeutics Corporation. He also has Other Disclosure for Actelion Pharmaceuticals, Gilead Sciences, United Therapeutics Corporation.

Return to top
 

Linda Carr has no relevant personal financial relationship to disclose.

Michael Carr has no relevant personal financial relationship to disclose.

Michelle Cash has received Institutional Grant/Research Support from Actelion Pharmaceuticals, Eli Lilly & Company, United Therapeutics Corporation.

Caryn Chasnov has no relevant personal financial relationship to disclose.

Murali Chakinala is a consultant for Actelion Pharmaceuticals US, Inc.; Gilead Sciences, Inc.; United Therapeutics Corporation; Bayer HealthCare and Medtronic, Inc. He is on speakers bureaus for Gilead Sciences, Inc. and United Therapeutics Corporation and receives research support from Actelion Pharmaceuticals US, Inc.; Gilead Sciences, Inc.; United Therapeutics Corporation; Bayer HealthCare; Novartis Pharmaceuticals; Ikaria, Inc.; Medtronic, Inc.; Aires and Reata Pharmaceuticals, Inc.

Richard Channick is a consultant for Actelion Pharmaceuticals US, Inc.; Bayer HealthCare and United Therapeutics Corporation.

Hadi Chohan has no relevant personal financial relationship to disclose.

Lorinda Chung has no relevant personal financial relationship to disclose.

Megan Clarke has served as a Consultant/Advisory Board/Steering Committee member for The Medicine Company (Cangrelor Advisory Board).

Kevin Crawford has no relevant personal financial relationship to disclose.

Laura D'Anna has no relevant personal financial relationship to disclose.

Aliva De has no relevant personal financial relationship to disclose.

Jose Diaz-Gomez has no relevant personal financial relationship to disclose.

Jasper Dingemanse has been a Stock Shareholder of Actelion Pharmaceuticals Ltd.

Louise Durst has no relevant personal financial relationship to disclose.

Laura Duvall has served as a Consultant/Advisory Board/Steering Committee member for United Therapeutics Corporation.

Return to top
 

Jason Elinoff has no relevant personal financial relationship to disclose.

Gregory Elliott has served as a Consultant/Advisory Board/Steering Committee member for Ikaria, Bayer Pharmaceuticals. He has also received Institutional Grant/Research Support from Actelion Pharmaceuticals provided grant support to Intermountain Healthcare, Gilead provided grant support to Intermountain Healthcare, United Therapeutics and Lung Rx provided grants. In addition, he has received non-Institutional/Research Support from NIH provided grant support to Intermountain Healthcare.

Jean Elwing has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals, Lung LLC, United Therapeutics Corporation. She has also received Institutional Grant/Research Support from Actelion Pharmaceuticals, Gilead Sciences, United Therapeutics Corporation, Novartis Pharmaceuticals, Lung LLC, Ikaria, Aires, Arena, Reata.

Serpil Erzurum has no relevant personal financial relationship to disclose.

Harrison Farber is a consultant for Gilead Sciences, Inc.; Actelion Pharmaceuticals US, Inc.; United Therapeutics Corporation and Bayer HealthCare. He is on speakers bureaus for Gilead Sciences, Inc.; Actelion Pharmaceutics US, Inc. and Bayer HealthCare and receives grant support from Gilead Sciences, Inc. and United Therapeutics Corporation.

Megan Farraj has no relevant personal financial relationship to disclose.

Christine Feld has no relevant personal financial relationship to disclose.

Jeremy Feldman has served as a Consultant/Advisory Board/Steering Committee member for united therapeutics, Gilead Science, Bayer. He has also served on a Speaker’s Bureau for UT, Gilead, Bayer. In addition, he has received Institutional Grant/Research Support from Gilead, United Therapeutics Corporation.

Eric Fenstad has no relevant personal financial relationship to disclose.

Jeff Fineman has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals.

Saul Flores has no relevant personal financial relationship to disclose.

Jimmy Ford has served as a Consultant/Advisory Board/Steering Committee member for Gilead Sciences, Lung LLC, United Therapeutics Corporation. In addition, he has served on a Speaker’s Bureau for Gilead Sciences, Actelion Pharmaceuticals, United Therapeutics Corporation. He has received Institutional Grant/Research Support from United Therapeutics Corporation. He has also received non-Institutional/Research Support from Actelion Pharmaceuticals.

Hiroyuki Fukushima has no relevant personal financial relationship to disclose.

Sean Gaine has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals, GlaxoSmithKline, Bayer HealthCare, United Therapeutics Corporation.

Alice Gallo de Moraes has no relevant personal financial relationship to disclose.

Mary George has no relevant personal financial relationship to disclose.

Paresh Giri has no relevant personal financial relationship to disclose.

Mardi Gomberg-Maitland is a consultant for Actelion Pharmaceuticals US, Inc.; Gilead Sciences, Inc.; Bayer HealthCare; Medtronic, Inc.; Ikaria, Inc.; PCORI Rare Diseases Advisory Panel and United Therapeutics Corporation and a special employee of the US Food and Drug Administration. The University of Chicago receives research grants from Actelion Pharmaceuticals US, Inc.; Gilead Sciences, Inc.; Medtronic, Inc. and Novartis Pharmaceuticals.

Daniel Gorbett has no relevant personal financial relationship to disclose.

Kara Goss has no relevant personal financial relationship to disclose.

Brian Graham has received Institutional Grant/Research Support from Gilead Sciences, Novartis Pharmaceuticals. He has also received non-Institutional/Research Support from NIH, Parker B Francis Foundation.

Michael Patrick Gray has no relevant personal financial relationship to disclose.

Amber Gygi has no relevant personal financial relationship to disclose.

Brian Hanna has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals. He has also received Institutional Grant/Research Support from Actelion, United therapeutics, Eli Lily, Gilead Sciences.

Sif Hansdottir has received Institutional Grant/Research Support from PI at the University of Iowa for industry sponsored trials - Actelion, Gilead, UT, Bayer, Ikaria.

Rebekah Hanson has served as a Consultant/Advisory Board/Steering Committee member for United Therapeutics Corporation. She has also served on a Speaker’s Bureau for United Therapeutics Corporation.

Bryan Hay has no relevant personal financial relationship to disclose.

Anna Hemnes has served as a Consultant/Advisory Board/Steering Committee member for United Therapeutics Corporation, Bayer. She has also  received non-Institutional/Research Support from NIH. In addition, she has Other Disclosure for Annamometer, LLC, Pfizer.

Kristin Highland has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals, United Therapeutics Corporation, Lung LLC, Bayer HealthCare, Gilead Sciences. She has also served on a Speaker’s Bureau for Gilead Sciences, Actelion, United Therapeutics Corporation, Lung LLC, Bayer HealthCare.

Monique Hinchcliff has no relevant personal financial relationship to disclose.

Meredith Howell has received Institutional Grant/Research Support from United Therapeutics Corporation. She has also been a Stock Shareholder of United Therapeutics Corporation.

Jeryl Huckaby has no relevant personal financial relationship to disclose.

Marc Humbert has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals, Bayer HealthCare, GSK, Novartis Pharmaceuticals, Pfizer. He has also received Institutional Grant/Research Support from Inserm, Université Paris-Sud, Fondation Recherche Médicale.

Cheol Hwangbo has no relevant personal financial relationship to disclose.

Dunbar Ivy indicates that the University of Colorado receives consultant fees from Actelion Pharmaceuticals US, Inc.; Bayer HealthCare; Gilead Sciences, Inc. and United Therapeutics Corporation.

Return to top
 

Miriam Jacob has no relevant personal financial relationship to disclose.

Vijay Joish has been a Stock Shareholder of Bayer HealthCare. He also has Other Disclosure for Bayer HealthCare.

Sharon Jones has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals.

Darya Kaborda has no relevant personal financial relationship to disclose.

Steven Kawut has no relevant personal financial relationship to disclose.

Anne Keogh has served as a Consultant/Advisory Board/Steering Committee member for Actelion speaker, clinical research projects, GSK speaker, Novartis clinical research, Pfizer clinical research , Bayer clinical researcher. She has served on a Speaker’s Bureau for Actelion Pharmaceuticals, GSK. She has also received Institutional Grant/Research Support from Actelion Pharmaceuticals US, Bayer, Novartis. She has received non-Institutional/Research Support from Actelion.

Kim Kerr has served as a Consultant/Advisory Board/Steering Committee member for Bayer. She has received Institutional Grant/Research Support from Bayer.

Dinesh Khanna has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals US, Bayer HealthCare, Bristol-Myers Squibb, Digna Biotech, Genentech Inc., Merck & Company, GlaxoSmithKline, and United Therapeutics Corporation. He has received Institutional Grant/Research Support from the NIH/NIAMS, Pulmonary Hypertension Association, and the Scleroderma Foundation.

Eunji Kim has no relevant personal financial relationship to disclose.

Hyong (Nick) Kim has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals and Bayer Healthcare. He has also served on a Speaker's Bureau for Actelion Pharmaceuticals US and Bayer Healthcare. In addition, he has received Institutional Grant/Research Support from Aires, Lung Biotechnology, Gilead Sciences, and United Therapeutics Corporation.

Amy Kimber has served as a Consultant/Advisory Board/Steering Committee member for Bayer HealthCare and United Therapeutics Corporation.

Abraham Kline has no relevant personal financial relationship to disclose.

Nina Kohn has no relevant personal financial relationship to disclose.

Richard Krasuski has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals, VentriPoint, Bayer HealthCare. He has also served on a Speaker’s Bureau for Actelion Pharmaceuticals.

Shawn Kristopher has no relevant personal financial relationship to disclose.

Ravinder Kumar has no relevant personal financial relationship to disclose.

Tim Lahm has served as a Consultant/Advisory Board/Steering Committee member for France Foundation, American College of Chest Physicians. He has also served on a Speaker’s Bureau for Bayer. In addition, he has received Institutional Grant/Research Support from received research funding from Gilead, received research funding from Pfizer. He has received non-Institutional/Research Support from  Indiana University and Department of Veterans Affairs.

Kevin Laliberte has Other Disclosure for United Therapeutics Corporation.

Return to top
 

Lindy Landzaat has no relevant personal financial relationship to disclose.

Cynthia Larew has no relevant personal financial relationship to disclose.

Deborah Jo Levine has no relevant personal financial relationship to disclose.

Katie Lutz has no relevant personal financial relationship to disclose.

Melissa Lyle has no relevant personal financial relationship to disclose.

Roberto Machado has served a Consultant/Advisory Board/Steering Committee member for United Therapeutics Corporation. He has received Institutional Grant/Research Support from the NIH, Actelion Pharmaceuticals, and United Therapeutics Corporation.

Catherina Madani has no relevant personal financial relationship to disclose.

Sally Maddox has no relevant personal financial relationship to disclose.

Jun Maeda has no relevant personal financial relationship to disclose.

Keith Marsolo has no relevant personal financial relationship to disclose.

Stephen Mathai is a consultant for Bayer HealthCare and Actelion Pharmaceuticals US, Inc.

Deb McBride has received non-Institutional/Research Support from Society of Critical Care Medicine.

Michael McGoon has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals, Lung LLC, GlaxoSmithKline.

Avery McKee has served as a Consultant/Advisory Board/Steering Committee member for United Therapeutics Corporation, Gilead, Acetlion, Bayer. She has also served on a Speaker’s Bureau for United Therapeutics Corporation, Gilead, Actelion, Bayer. In addition, she has received Institutional Grant/Research Support from United Therapeutics Corporation. She has received non-Institutional/Research Support from Gilead Sciences. She is also a Stock Shareholder of Actelion Pharmaceuticals. She has Other Disclosure for Bayer HealthCare.

Vallerie McLaughlin has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals, Bayer, Gilead, United Therapeutics, Merck, CVS Caremark. She has also served on a Speaker’s Bureau for Gilead Sciences. She has received Institutional Grant/Research Support from Actelion Pharmaceuticals, Bayer HealthCare, Novartis Pharmaceuticals, Gilead Sciences, Inc. and Ikaria. In addition, she has received non-Institutional/Research Support from cmref.

Evangelos Michelakis is part of a committee that consults for the Actelion ENTELLIGENCE program to award scientific grants to young investigators in the field of pulmonary hypertension. He is also a steering committee member for Bayer HealthCare for the conduction of a riociguat clinical trial and a consultant for United Therapeutics Corporation.

Omar Minai has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals, Gilead Sciences, United Therapeutics Corporation, Bayer Healthcare. He has also served on a Speaker's Bureau for Actelion Pharmaceuticals US and United Therapeutics Corporation.

Hideya Mukai has no relevant personal financial relationship to disclose.

John Newman has no relevant personal financial relationship to disclose.

Bill Nichols has received Institutional Grant/Research Support from NIH.

Return to top
 

Kaori Okubo has no relevant personal financial relationship to disclose.

Rita Orth has no relevant personal financial relationship to disclose.

Ronald Oudiz has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals, Bayer HealthCare, Gilead Sciences, Lung LLC, Medtronic, Pfizer, United Therapeutics Corporation, Reata. He has served on a Speaker’s Bureau for Actelion Pharmaceuticals, Gilead Sciences, Lung LLC, United Therapeutics Corporation, Bayer HealthCare. In addition, he has received Institutional Grant/Research Support from Actelion Pharmaceuticals, Bayer HealthCare, Ikaria, Lung LLC, Pfizer, United Therapeutics Corporation, Reata.

Takayuki Oyanagi has no relevant personal financial relationship to disclose.

Purvesh Patel has no relevant personal financial relationship to disclose.

Vikas Pathak has no relevant personal financial relationship to disclose.

Michael Pauciulo has no relevant personal financial relationship to disclose.

Irina Petrache has received Institutional Grant/Research Support from Biomet Inc, Harrington Institute, NHLBI. She has Other Disclosure for Emphymab.

Cindy Pickles has no relevant personal financial relationship to disclose.

Abby Poms has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals, Bayer HealthCare, Ikaria, United Therapeutics Corporation, Reata, GSK, Lung LLC, Gilead Sciences. She has also served on a Speaker’s Bureau for Actelion Pharmaceuticals, United Therapeutics Corporation.

Jayant Pratap has no relevant personal financial relationship to disclose.

Ioana Preston has served as a Consultant/Advisory Board/Steering Committee member for Actelion, Bayer HealthCare, Gilead Sciences, United Therapeutics Corporation, Aires. She has also received Institutional Grant/Research Support from Actelion Pharmaceuticals, Bayer HealthCare, Gilead Sciences, United Therapeutics Corporation, Aires.

Marc Pritzker has no relevant personal financial relationship to disclose.

Meredith Pugh has no relevant personal financial relationship to disclose.

Diane Ramirez has no relevant personal financial relationship to disclose.

Farrid Rashidi has no relevant personal financial relationship to disclose.

Jessica Reid has no relevant personal financial relationship to disclose.

Auvo Reponen has no relevant personal financial relationship to disclose.

Kari Roberts has received Institutional Grant/Research Support from NHLBI.

Frances Rogers has served as a Consultant/Advisory Board/Steering Committee member for Gilead Sciences.

Alain Romero has been a Stock Shareholder of Actelion Pharmaceuticals. He has Other Disclosure for Actelion Pharmaceuticals.

Frances Russell has no relevant personal financial relationship to disclose.

Bill Sacks has no relevant personal financial relationship to disclose.

Jeffrey Sager has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals, Gilead Sciences, United Therapeutics Corporation, Lung LLC. He has also received Institutional Grant/Research Support from Actelion Pharmaceuticals, United Therapeutics Corporation, Lung LLC, Gilead Sciences.

Rajan Saggar has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals US, Gilead Sciences, Bayer HealthCare, and United Therapeutics Corporation. He has also served on a Speaker's Bureau for Actelion Pharmaceuticals US, Bayer HealthCare, Gilead Sciences, and United Therapeutics Corporation. He has received Institutional Grant/Research Support from United Therapeutics Corporation.

Sonu Sahni has no relevant personal financial relationship to disclose.

Riccardo Scagliola has no relevant personal financial relationship to disclose.

Linda Schieb has no relevant personal financial relationship to disclose.

Robert Schilz has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals US, Gilead Sciences, United Therapeutics Corporation, Bayer HealthCare. He has also served on a Speaker’s Bureau for Actelion Pharmaceuticals, Gilead Sciences, United Therapeutics Corporation, Bayer HealthCare. In addition, he has received Institutional Grant/Research Support from Actelion Pharmaceuticals, Bayer HealthCare, GeNo, Ikaria, United Therapeutics Corporation, GlaxoSmithKline, Boehringer-Ingelheim.

Page Scovel has no relevant personal financial relationship to disclose.

Sanjiv Shah has served as a Consultant/Advisory Board/Steering Committee member for Bayer HealthCare, Novartis AG, DC Devices. He has received Institutional Grant/Research Support from the NIH.

Akimichi Shibata has no relevant personal financial relationship to disclose.

Marc Simon receives research support from the National Institutes of Health and Aires Pharmaceuticals.

Edda Spiekerkoetter receives a grant from the National Institutes of Health to study modulation of BMP signaling, which includes the drug FK506. She is listed as an inventor on a patent application for the use of FK506 in PAH.

Virginia Steen has served as a Consultant/Advisory Board/Steering Committee member for Gilead Science, United Therapeutics, Bristol Meyers-Squib, Bayer, Actelion Pharmaceuticals. She has also served on a Speaker’s Bureau for Actelion Pharmaceuticals, Gilead Sciences. In addition, she has received Institutional Grant/Research Support from Actelion Pharmaceuticals, Gilead Sciences, United Therapeutics Corporation, Sanofi, Roche Diagnostics, CSL Berlinger.

Duncan Stewart has served as a Consultant/Advisory Board/Steering Committee member for Baxter. He has also received Institutional Grant/Research Support from Northern Therapeutics. He has been a Stock Shareholder of Northern Therapeutics.

Traci Stewart has served as a Consultant/Advisory Board/Steering Committee member for Bayer HealthCare.

Sean Studer has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals US, Bayer HealthCare, Gilead Sciences, and United Therapeutics Corporation. He has served on a Speaker's Bureau for Actelion Pharmaceuticals US, Bayer HealthCare, Gilead Sciences, and United Therapeutics Corporation.

Jacqueline Szmuskovicz has no relevant personal financial relationship to disclose.

Return to top

Arunabh Talwar has no relevant personal financial relationship to disclose.

Rudhir Tandon has no relevant personal financial relationship to disclose.

Holly Taylor has no relevant personal financial relationship to disclose.

Anita Tevanian has no relevant personal financial relationship to disclose.

Fernando Torres receives research support from Gilead Sciences, Inc.; Bayer HealthCare; Medtronic, Inc., Akaria, Inc., GeNO; Reata Pharmaceuticals, Inc. and Arena. He is also an advisory board member for Gilead Sciences, Inc.; Actileon Pharmaceuticals US, Inc.; United Therapeutics Corporation and Bayer HealthCare; a speaker for Actelion Pharmaceuticals US, Inc., United Therapeutics Corporation and Bayer HealthCare; and a consultant for Actelion Pharmaceuticals US, Inc.

Roger Towle has no relevant personal financial relationship to disclose.

Glenna Traiger has served as a Consultant/Advisory Board/Steering Committee member for Actelion Pharmaceuticals US, Gilead Sciences, United Therapeutics Corporation. She has also served on a Speaker's Bureau for Actelion Pharmaceuticals US, Gilead Sciences, and United Therapeutics Corporation.

Rizalyn Vargas has no relevant personal financial relationship to disclose.

Sameer Verma has no relevant personal financial relationship to disclose.

Tania von Visger has no relevant personal financial relationship to disclose.

Anna Walsworth has no relevant personal financial relationship to disclose.

Gerrit Weimann has received non-Institutional/Research Support from Bayer Pharma.

Norbert Weissmann applied for a patent to use L-NIL for lung regeneration.

Lisa Wheeler has received Institutional Grant/Research Support from PHA-Tom Lantos Award.

Stephen White has no relevant personal financial relationship to disclose.

Melisa Wilson has no relevant personal financial relationship to disclose.

Thomas Wilson has no relevant personal financial relationship to disclose.

Joel Wirth has received Institutional Grant/Research Support from Actelion , Bayer, United Therapeutics Corporation.

Scott Visovatti has no relevant personal financial relationship to disclose.

Hiroyuki Yamagishi has no relevant personal financial relationship to disclose.

Delphine Yung has served as a Consultant/Advisory Board/Steering Committee member for Eli Lilly & Company, United Therapeutics Corporation. She has also received Institutional Grant/Research Support from United Therapeutics Corporation.

Lei Xiao has no relevant personal financial relationship to disclose.

Roham Zamanian has no relevant personal financial relationship to disclose.

 Last Updated: June 18, 2014

Return to top
 

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

For the best viewing experience of this site, it is recommended that you use Internet Explorer 8 or 9 or Firefox.

© 2014 Pulmonary Hypertension Association. All Rights Reserved.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
Webmaster@PHAssociation.org
    Privacy Policy   Virtual Tour of Website    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.®

NORD

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.